Sucampo

A star drug in Mallinckrodt’s $1.2B Sucampo buyout flops in pivotal trial
Endpoints
Wed, 11/7/18 - 12:31 pm
Mallinckrodt
Sucampo
Niemann-Pick disease
Mother Alleges Biotech Firm Stole Data From Her Sick Children
Forbes
Mon, 01/8/18 - 09:40 am
biotech
Sucampo
Vtesse
Cydan
patient data
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Biopharma Dive
Thu, 12/28/17 - 09:20 am
Mallinckrodt
Sucampo
M&A
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
M&A
Allergan
Alnylam
Biomarin
Bristol-Myers Squibb
Incyte
Madrigal Pharmaceuticals
Spark Therapeutics
Sucampo
Here’s why Sucampo paid $200M for its PhIII Niemann-Pick drug
Endpoints
Fri, 08/11/17 - 11:21 am
Sucampo
Niemann-Pick disease
cyclodextrin
Sucampo bags rare disease player Vtesse in $200M buyout agreement
Endpoints
Mon, 04/3/17 - 09:16 am
Sucampo
Vtesse
M&A
VTS-270
Sucampo tops 4Q revenue forecasts
Yahoo/AP
Wed, 03/8/17 - 09:45 am
Sucampo
earnings
Sucampo Q4 Beats Estimates, Affirms Guidance, Driving Up Stock
Investors.com
Tue, 03/8/16 - 06:15 pm
Sucampo
earnings
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
Why does Sucampo want to acquire its founders' Japanese company? Transformation.
Bizjournals.com
Thu, 08/27/15 - 05:28 pm
Sucampo
Japan
M&A
Sucampo Pharma to Make Tender Offer For Japan's R-Tech Ueno
Bloomberg
Wed, 08/26/15 - 10:40 am
Sucampo
M&A
Japan
R-Tech Ueno
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Sucampo posts profit of $1.5 million in third quarter
Yahoo/AP
Thu, 11/6/14 - 08:05 am
Sucampo
earnings
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
Yahoo
Thu, 10/23/14 - 08:36 am
Takeda
Sucampo
Amitiza
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Fri, 02/21/14 - 11:19 am
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Sucampo initiates global Phase 3 clinical program of lubiprostone
The Fly on the Wall
Tue, 12/17/13 - 08:55 am
Sucampo
Lubiprostone
pediatric functional constipation
Sucampo CEO search an unexpected positive, says Cantor
Yahoo/Fly on the Wall
Fri, 08/9/13 - 01:16 pm
Sucampo
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Thu, 06/27/13 - 10:34 am
Sucampo
Takeda
Amitiza
opioid-induced constipation
Sucampo to be Added to the NASDAQ Biotechnology Index
Yahoo
Wed, 05/15/13 - 09:29 am
NASDAQ
Sucampo
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Tue, 04/23/13 - 10:49 am
Sucampo
Amitiza
opioid-induced constipation

Pages